Intracranial Stents Market: Growth, Trends & Forecast to 2035

Introduction

The Global Intracranial Stents Market is experiencing continued growth, driven by the increasing prevalence of cerebrovascular disorders, a growing elderly population, and rising adoption of minimally invasive neurovascular procedures. Intracranial stents are used to support the treatment of conditions such as brain aneurysms and intracranial stenosis. Technological advancements are improving stent flexibility, navigability, radial strength, and compatibility with advanced imaging techniques, supporting wider clinical adoption.

Get Free Sample Of This Premium Report

https://www.decisionsadvisors.com/request-sample/DAR4308

Intracranial Stents Market Insights

The Global Intracranial Stents Market was valued at approximately USD 4.65 Billion in 2024 and is projected to reach around USD 8.23 Billion by 2035.

From 2025 to 2035, the market is expected to grow at a CAGR of 5.33%. Increasing cerebrovascular disease prevalence, technological advancements in neurovascular devices, growing preference for minimally invasive procedures, and improvements in reimbursement are among the factors supporting market expansion.

Based on Product Type, Self-Expanding Stents accounted for the largest market share in 2024 and are anticipated to grow at a significant CAGR during the forecast period. Their flexibility, ease of deployment, and suitability for complex cerebral arteries contribute to their clinical adoption in intracranial stenosis and aneurysm procedures.

Based on Disease Indication, Brain Aneurysm accounted for the highest revenue share in 2024 and is projected to grow at a notable CAGR over the forecast period. The segment is supported by the increasing use of stent-assisted coil embolisation and flow-diverting stents, along with continued advances in neurovascular technologies.

Other Key Findings

• Asia-Pacific is anticipated to hold the largest share of the global intracranial stents market over the forecast period.
• Europe is expected to grow at a rapid CAGR during the forecast period.
• China and India are identified as important growth markets within Asia-Pacific, supported by growing patient populations, healthcare investment, research funding, and increasing awareness of intracranial stent procedures.
• Increasing preference for minimally invasive neurovascular procedures is supporting demand for intracranial stents.
• Continuous product development is focused on improving flexibility, navigability, radial strength, and treatment precision.
• High device costs, complex regulatory approvals, the need for specialized neuro-interventional expertise, and concerns regarding long-term safety and restenosis remain market challenges.

Report Summary

The report provides revenue forecasts at global, regional, and country levels and evaluates market drivers, opportunities, challenges, trends, competitive strategies, and recent developments.

Segmentation Covered

Regional Coverage

• North America: U.S., Canada, Mexico
• Europe: Germany, UK, France, Italy, Spain, Russia, Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, Australia, Rest of Asia-Pacific
• South America: Brazil, Argentina, Rest of South America
• Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of the Middle East & Africa

Report Coverage

The Global Intracranial Stents Market report provides comprehensive coverage of:

• Revenue forecasts and market sizing
• Product type analysis
• Disease indication analysis
• Regional and country-level analysis
• Market growth drivers
• Industry trends and opportunities
• Market restraints and challenges
• Technological developments
• Competitive landscape
• Company strategies
• Product development and innovation
• Partnerships, mergers, and acquisitions
• Strategic analysis of key market participants

Companies

The key companies profiled in the Global Intracranial Stents Market include:

• Abbott Laboratories
• Acandis GmbH
• Admedes Schuessler GmbH
• Balt Extrusion S.A.
• Cardiatis, S.A.
• Covidien Ltd
• DePuy Synthes Companies
• Medtronic Public Limited Company
• MicroPort Scientific Corporation
• OBEX Medical Limited
• Penumbra, Inc.
• Phenox GmbH
• Stryker Corporation
• Terumo Corporation
• Others

Recent Market Developments

• In December 2023, researchers from King's College London reported safety findings for a revised flow-diverting stent device intended to stop blood flow into brain aneurysms.
• In January 2022, MicroPort NeuroTech announced enrollment of the first patient in the PROMISE Study for the Rebridge® Intracranial Visualised Stent, beginning clinical evaluation of the device for intracranial aneurysms.
• The report also highlights developments involving Ceroflo's SubMax technology and Oxford Endovascular's OXIFLOW technology, reflecting ongoing innovation in neurovascular intervention.

Want detailed insights, forecasts, and competitive analysis?

Check out the full Global Intracranial Stents Market report:

https://www.decisionsadvisors.com/reports/intracranial-stents-market